Ultradian variations of chromogranin A in humans

Am J Physiol. 1991 Oct;261(4 Pt 2):R939-44. doi: 10.1152/ajpregu.1991.261.4.R939.

Abstract

Chromogranin A (CgA) is an acidic soluble protein exocytotically released from virtually all neuroendocrine secretory vesicles. Here we examined spontaneous variations in CgA and catecholamine concentrations in humans. In normal subjects, basal CgA showed no day-to-day, week-to-week, or diurnal variability. Plasma CgA had significant ultradian variation in normotensives and hypertensives, and in bilaterally adrenalectomized subjects. Gender, but not age or blood pressure, influenced CgA variations, males having fewer (P less than 0.05) peaks per 8 h. Plasma catecholamines had significant ultradian variations in both controls and bilaterally adrenalectomized subjects. Within individuals, neither basal nor peak plasma CgA correlated with catecholamines, nor was there concordance between plasma CgA and catecholamine peaks. Somatostatin, a widespread inhibitor of nonsympathoadrenal neuroendocrine secretion, diminished both the frequency and amplitude of plasma CgA peaks. Thus spontaneous variations in basal CgA are not directly linked to alterations in sympathoadrenal catecholamine secretion. Furthermore, neuroendocrine secretion at sites other than the sympathoadrenal system contributes to spontaneous variations in CgA concentration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Activity Cycles*
  • Adrenalectomy
  • Adult
  • Aged
  • Chromogranin A
  • Chromogranins / blood*
  • Epinephrine / blood
  • Female
  • Humans
  • Male
  • Middle Aged
  • Norepinephrine / blood
  • Osmolar Concentration
  • Sex Characteristics
  • Somatostatin / pharmacology

Substances

  • CHGA protein, human
  • Chromogranin A
  • Chromogranins
  • Somatostatin
  • Norepinephrine
  • Epinephrine